Historical Controls For Epilepsy Studies To Be Considered By Advisory Cmte.

GlaxoSmithKline's Lamictal XR and several drugs in the pipeline could see their quest for monotherapy indications affected by what the Peripheral and Central Nervous System Drugs Advisory Committee decides.